Delivery Order SPE2DE24D0013-SPE2D625F3SEY
- Not listed
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $22,926.50 by the Medical Supply Chain division of the Department of Defense on September 8, 2025, with a completion date of September 15, 2025. The delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries no set-aside designation, has an ultimate completion date of July 25, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with Cepheid's existing Indefinite...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $13,600 by the Medical Supply Chain, a defense-oriented federal agency, on June 2, 2025. The contract, designated as XPRS4PLEX-10 with completion scheduled for June 9, 2025, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale. This delivery order represents a discrete procurement action within Cepheid's broader...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3SEYDelivery Order
Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, received a delivery order award valued at $7,179.06 from the Defense Department's Medical Supply Chain division on September 17, 2025. This firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by October 1, 2025, and represents performance at Cepheid's Sunnyvale, CA facility. The award continues Cepheid's substantial engagement with federal healthcare systems, particularly the Department of Veterans Affairs and Defense Logistics Agency, in supplying diagnostic equipment and testing solutions. This delivery order falls under Cepheid's broader portfolio of federal molecular diagnostic contracts, which includes significant Indefinite Delivery Vehicle agreements such as a $32.8 million IDV with VA's Veterans Integrated Service Network 6 and a $2.5 million IDV with VA's Veterans Integrated Service Network 21. Cepheid's federal work focuses on providing GeneXpert diagnostic systems, molecular reagents, and test kits for detecting infectious diseases including COVID-19, influenza, RSV, and other clinical conditions. The modest contract ceiling on this particular delivery order reflects the incremental nature of procurement through these larger federal vehicles, enabling the government to obtain diagnostic solutions on an as-needed basis while leveraging established pricing and terms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/17/25 |